Table 3 Differences of risk factors and clinical findings between the two outcome groups

Age, y, median (IQR)

75 (70, 78.75)

72 (66, 75)

3.658^a

Male, n (%)

58 (58.0)

80 (53.0)

0.612^c

Smoking, n (%)

24 (24.0)

38 (25.2)

0.044^c

Hypertension, n (%)

83 (83.0)

113 (74.8)

2.344^c

Diabetes mellitus, n (%)

23 (23.0)

29 (19.2)

0.527^c

Hyperlipidemia, n (%)

14 (14.0)

29 (19.2)

1.148^c

Congestive heart failure, n (%)

30 (30.0)

22 (14.6)

8.721^c

Baseline SBP (mm Hg, ‾x ± s)

149.6 ± 24.5

143.5 ± 19.0

2.113^b

Baseline DBP (mm Hg, ‾x ± s)

87.9 ± 14.1

85.0 ± 12.6

1.707^b

Baseline NIHSS score, median (IQR)

15 (11, 19)

4 (2, 7)

11.150^a

Moderate-severe LA, n (%)

39 (39.0)

24 (15.9)

17.084^c

sICH, n (%)

17 (17.0)

10 (6.6)

6.749^c

nsICH, n (%)

30 (30.0)

16 (10.6)

15.133^c

SAP, n (%)

66 (66.0)

13 (8.6)

63.224^c

Anticoagulant therapy, n (%)

56 (56.0)

64 (42.4)

0.022^c

Stroke recurrence, n (%)

4 (4.0)

4 (2.6)

0.004^c

Laboratory findings, mmol/l

Total cholesterol (‾x ± s)

4.1 ± 0.9

4.1 ± 0.8

0.703^b

Triglyceride (‾x ± s)

1.0 ± 0.4

1.3 ± 0.9

-2.843^b

LDL-C (‾x ± s)

2.3 ± 0.7

2.2 ± 0.7

1.412^b

Fasting glucose (‾x ± s)

7.0 ± 2.7

5.8 ± 1.7

3.844^b